COVID-19 Actuaries Response Group

The Friday Report – Issue 5

Bulletin 22 | Matt Fletcher, Nicola Oliver and Andre Gaches

Every week, more is written on COVID-19 than any individual could possibly read. Collectively, the COVID-19 Actuaries Response Group read more about the outbreak than most, so we’ve decided each Friday to provide you with a curated list of the key papers and articles that we’ve looked at recently.

In this report:

  • The role of testing in COVID-19 control
  • Clinical characteristics and predictors of outcomes in hospitalised patients with COVID-19
  • The role of genes in COVID-19 symptoms
  • Features of hospitalised UK patients with COVID-19
  • IFS report on wider impacts of the pandemic on the NHS
  • Estimating the burden of United States workers exposed to infection or disease
  • Remdesivir in adults with severe COVID-19
  • Internet searches for unproven COVID-19 therapies in the United States
  • Analysis of SARS-CoV-2 viral load by patient age
  • Concern that a COVID-19 related inflammatory syndrome is emerging in children
  • ONS analysis by local area and socioeconomic deprivation
  • UK deaths in care homes and deaths from other causes
Avatar photo

Matthew Fletcher

Senior Consultant - AON

Matt has over 20 years’ consultancy experience, including over 10 years as a specialist in mortality and longevity. He works in Aon’s Demographic Horizons team, advising insurance companies and pension funds on setting best estimates and evaluating risk for longevity and other demographic assumptions, both in the UK and overseas.

Matt chairs the CMI Self-Administered Pension Schemes (SAPS) Committee, which produces mortality tables that are used extensively in the pensions and insurance industries.

Avatar photo

Nicola Oliver

Director of Life & Health - Medical Intelligence

Nicola is considered a leading expert in Public Health and associated Mortality, Morbidity & Longevity risk.

Areas of specialist knowledge include; public health policy, socioeconomic disparities, impact of risk behaviours on life expectancy & future infectious disease risks.

Nicola supports actuaries from many of the leading consultancies, pension & insurance companies in Europe and the US, with underwriting, annuity pricing, product development as well as internal model calibration to fulfil regulatory requirement.

She leads a small research team within Medical Intelligence and continues to regularly present her work and speak at events for and on behalf of clients and to wider public audiences.

Prior to co-founding Medical Intelligence in 2007, Nicola worked for the NHS for 19 years specialising in Public Health, this followed many years in senior roles in Intensive Care Nursing and Paediatrics.

Nicola trained as a nurse and subsequently studied at Homerton College University of Cambridge, graduating with a PgDip in Neonatal Special and Intensive Care followed up with a BSc (Hons) in Public Health (Specialist Community).

Nicola has also studied Epidemiology with the London School of Hygiene & Tropical Medicine and Statistics.

Avatar photo

Andrew Gaches

Partner, Head of Longevity - Hymans Robertson

Andrew has 25 years consulting experience, advising pension funds, insurers and reinsurers, and leads Hymans Robertson’s award-winning longevity services for insurance clients.

His expertise was central to the establishment of Club Vita and he now focuses on guiding clients through the process of recognising, quantifying and managing the longevity risk they face.

Andrew is a regular speaker at conferences, has written articles and authored papers on longevity, and is a long standing member of CMI committees and working parties.

Follow us

Don't be shy, get in touch. We love meeting interesting people and making new friends.

Most popular